[1]杨秀霞.妈富隆治疗上环后子宫异常出血的效果[J].医学信息,2020,(11):145-146.[doi:10.3969/j.issn.1006-1959.2020.11.046]
 YANG Xiu-xia.Effect of Marvelon on Abnormal Uterine Bleeding After Upper Ring[J].Medical Information,2020,(11):145-146.[doi:10.3969/j.issn.1006-1959.2020.11.046]
点击复制

妈富隆治疗上环后子宫异常出血的效果()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2020年11期
页码:
145-146
栏目:
药物与临床
出版日期:
2020-06-01

文章信息/Info

Title:
Effect of Marvelon on Abnormal Uterine Bleeding After Upper Ring
文章编号:
1006-1959(2020)11-0145-02
作者:
杨秀霞
(天津市东丽区东丽医院妇科,天津 300350)
Author(s):
YANG Xiu-xia
(Department of Gynecology,Dongli Hospital,Dongli District,Tianjin 300350,China)
关键词:
上环子宫异常出血妈富隆
Keywords:
Upper ringAbnormal uterine bleedingMarvelonClinical efficacy
分类号:
R711.74
DOI:
10.3969/j.issn.1006-1959.2020.11.046
文献标志码:
A
摘要:
目的 探讨妈富隆治疗上环后子宫异常出血的效果。方法 选取2018年1月~2019年1月我院收治的上环后子宫异常出血患者80例,按照随机数字表法分为对照组和观察组,每组40例。对照组给予米非司酮治疗,观察组给予妈富隆治疗,比较两组临床效果、止血时间、子宫内膜厚度及不良事件发生情况。结果 观察组临床总有效率为97.50%,高于对照组的77.50%,差异有统计学意义(P<0.05);观察组止血时间短于对照组[(34.15±6.31)h vs(46.82±8.26)h],子宫内膜厚度小于对照组[(5.31±1.74)mm vs(7.83±1.67)mm],差异有统计学意义(P<0.05);观察组不良事件发生率为5.00%,低于对照组的20.00%,差异有统计学意义(P<0.05)。结论 妈富隆治疗上环后子宫异常出血效果确切,可有效缩短止血时间,降低子宫内膜厚度,且可减少不良事件的发生,安全性较高。
Abstract:
Objective To explore the effect of Marvelon on the treatment of abnormal uterine bleeding after upper ring.Methods Selecting 80 patients with abnormal uterine bleeding after upper ring admitted in our hospital from January 2018 to January 2019, and divided into a control group and an observation group according to random number table method, with 40 cases in each group. The control group was treated with mifepristone, and the observation group was treated with Marvelon. The clinical effect, hemostasis time, endometrial thickness and adverse events were compared between the two groups.Results The total clinical effective rate of the observation group was 97.50%, which was higher than 77.50% that of the control group, the difference was statistically significant (P<0.05); the bleeding time of the observation group was shorter than that of the control group[(34.15±6.31)h vs(46.82±8.26)h], and the endometrial thickness was lower than that of the control group[(5.31±1.74)mm vs(7.83±1.67)mm], the difference was statistically significant(P<0.05); the incidence of adverse events in the observation group was 5.00%, lower than 20.00% in the control group, the difference was statistically significant(P<0.05).Conclusion Marvelon has a definite effect on the treatment of abnormal uterine bleeding after the upper ring, which can effectively shorten hemostasis time and reduce endometrial thickness, meanwhile reduce the occurrence of adverse events, improve the clinical symptoms of patients, and has high safety.

参考文献/References:

[1]罗伟飞,相美平.妈富隆用于改善放置宫内节育器初期子宫异常出血的临床研究[J].中国性科学,2016,25(5):129-132.[2]李帅,田巍.低剂量米非司酮联合妈富隆治疗功能性子宫出血的疗效及对患者雌二醇、卵泡刺激素和黄体生成素的影响[J].中国妇幼保健,2018,33(6):1227-1229.[3]刘晶静,唐苗苗,董利琴.益气化瘀方联合米非司酮治疗围绝经期子宫功能失调性出血的临床效果评价[J].中国性科学,2016,25(9):44-47.[4]崔麦玲.妈富隆单用或联合米非司酮用于无排卵型功能失调性子宫出血疗效观察及对性激素水平的影响[J].青岛医药卫生,2017,49(2):132-134.[5]张惠琴.妈富隆治疗上环后子宫异常出血的临床效果分析[J].实用妇科内分泌杂志(电子版),2017(17):65-66.[6]胡彦,李岚,黄文珍,等.妈富隆联合金刚藤胶囊治疗围绝经期功能性子宫出血的效果观察[J].广西医科大学学报,2017,34(2):262-265.

更新日期/Last Update: 1900-01-01